ALLR · Allarity Therapeutics Inc
United States · RS rating 50 · As of 2026-11-03
| Price | 1.13 USD |
|---|---|
| 1-day change | +15.5% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 86 / 37 / 35 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 18 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -23.5% |
| Sales growth Q/Q | -92.2% |
| Distance from 52-week high | +36.2% |
| Market cap (USD) | $22.1M |